Target: ₹8,500
CMP: ₹7,009.70
Navin Fluorine International has established a robust presence across various sectors, including Contract Development and Manufacturing Organization (CDMO), Specialty Chemicals, and High-Performance Products (HPP). The company leverages its extensive expertise in fluorine chemistry, alongside backward integration, to cater to global clients in pharmaceuticals, agrochemicals, refrigerants, and specialty materials, with exports constituting approximately 70% of its revenue.
In the fourth quarter of FY26, Navin Fluorine reported a strong performance, with revenues rising 34% year-on-year to ₹938 crore. The CDMO segment experienced notable growth of 61%, while Specialty Chemicals and HPP rose by 39% and 20%, respectively, driven by firm pricing for HFC-32 and increased utilization rates.
Looking ahead, FY27 is anticipated to be a pivotal year as significant investments transition into revenue generation. The ramp-up of R-32 refrigerants in the HPP sector is expected to benefit from surging demand and favorable pricing. Additionally, debottlenecking of multi-purpose plants will enhance output in Specialty Chemicals and CDMO. A long-term manufacturing and supply agreement with Chemours in the United States is projected to contribute high-margin contracted revenues. Presently, the company maintains 80% visibility for capacity utilization in Specialty Chemicals, alongside a robust CDMO pipeline consisting of 50-55 molecules.
According to market consensus, Navin Fluorine is trading at a one-year forward price-to-earnings (P/E) ratio of 43x, which is below its five-year average. The outlook remains optimistic, bolstered by strong medium-term revenue visibility, structurally elevated EBITDA margins exceeding 30%, an increasing export mix, a solid CDMO order pipeline, and the commissioning of the Chemours project, combined with sustained growth in refrigerant gas and R-32 capacity ramp-up.
Published on May 5, 2026
